ArticleBiomedicines2022

Intraovarian Injection of Recombinant Human Follicle-Stimulating Hormone for Luteal-Phase Ovarian Stimulation during Oocyte Retrieval Is Effective in Women with Impending Ovarian Failure and Diminished Ovarian Reserve.

Chao-Chin Hsu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.